Purinergic signaling in kidney disease

scientific article

Purinergic signaling in kidney disease is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/J.KINT.2016.08.029
P698PubMed publication ID27780585

P50authorMatthew A BaileyQ61296994
P2093author name stringRobert I Menzies
Robert J Unwin
Frederick W Tam
P433issue2
P407language of work or nameEnglishQ1860
P304page(s)315-323
P577publication date2016-10-22
P1433published inKidney InternationalQ6404823
P1476titlePurinergic signaling in kidney disease
P478volume91

Reverse relations

cites work (P2860)
Q47108081A more tubulocentric view of diabetic kidney disease.
Q89013192A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector
Q47665974ATP induces PAD4 in renal proximal tubule cells via P2X7 receptor activation to exacerbate ischemic AKI.
Q42373746Acute In Vivo Analysis of ATP Release in Rat Kidneys in Response to Changes of Renal Perfusion Pressure.
Q89712805Alteration of purinergic signaling in diabetes: Focus on vascular function
Q47655859CD39-adenosinergic axis in renal pathophysiology and therapeutics
Q92993541Characterization of purinergic receptor expression in ARPKD cystic epithelia
Q92556588Comparative Embryonic Spatio-Temporal Expression Profile Map of the Xenopus P2X Receptor Family
Q97533995Conversion of extracellular ATP into adenosine: a master switch in renal health and disease
Q56350431Epithelial and Endothelial Pannexin1 Channels Mediate AKI
Q47313422Extracellular Adenosine Stimulates Vacuolar ATPase-Dependent Proton Secretion in Medullary Intercalated Cells
Q92860794Extracellular DNA traps in inflammation, injury and healing
Q47831593Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca2+ in knock-out mouse models of polycystic kidney disease.
Q33715745Hyperglycemia-induced Renal P2X7 Receptor Activation Enhances Diabetes-related Injury.
Q92648839Integration of purinergic and angiotensin II receptor function in renal vascular responses and renal injury in angiotensin II-dependent hypertension
Q58764683N6-(2-Hydroxyethyl) Adenosine From Ameliorates Renal Interstitial Fibrosis and Prevents Inflammation via TGF-β1/Smad and NF-κB Signaling Pathway
Q89839805P2X4 receptor exacerbates ischemic AKI and induces renal proximal tubular NLRP3 inflammasome signaling
Q92288763P2X7 Receptor Stimulation Is Not Required for Oxalate Crystal-Induced Kidney Injury
Q42367885Purinergic Signalling: Therapeutic Developments
Q37545416Renal disease pathophysiology and treatment: contributions from the rat.
Q57184176Role of calcium in adult onset polycystic kidney disease
Q90010767Sensing of tubular flow and renal electrolyte transport
Q90575170Shiga toxin signals via ATP and its effect is blocked by purinergic receptor antagonism
Q89619982Signaling of the Purinergic System in the Joint
Q50202418The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
Q47571865The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression
Q57820645The renal and blood pressure response to low sodium diet in P2X4 receptor knockout mice

Search more.